Subject: Technology:  MicroGeneSys AIDS Vaccine
Date: Published: 3/10/89 (27 lines)
Source:  Wall Street Journal.  Copyright Dow Jones & Co. Inc. 

    Technology:  
    MicroGeneSys AIDS Vaccine

    WEST HAVEN, Conn. -- MicroGeneSys Inc., which is testing
 an experimental vaccine against acquired immune deficiency
 syndrome, said it is launching a second test of the vaccine
 to see if it can prevent the onset of AIDS in healthy
 carriers of the virus.
    This approach, called immunotherapy, already is being
 tested by several groups including that of polio vaccine
 pioneer Jonas Salk in La Jolla, Calif.
    MicroGeneSys said it plans to test its VaxSyn vaccine
 preparation in 30 virus-positive volunteers who may be male
 or female but must be judged free of AIDS symptoms.  The test
 will involve a series of injections over 12 months.  The risk
 of the vaccine to volunteers is unknown, MicroGeneSys said.
 But prior tests in healthy uninfected volunteers haven't
 resulted in any serious adverse reactions, the company said.

[This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.]